Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging

Annals of the American Thoracic Society - United States
doi 10.1513/annalsats.201609-680aw
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Mammalian Target of Rapamycin (mTOR) Pathways in Neurological Diseases

Biomedical Journal
Medicine
2013English

Mammalian Target of Rapamycin (mTOR; FRAP; RAFT1)

Science-Business eXchange
2010English

Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin

Clinical Cancer Research
Cancer ResearchOncology
2008English

Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2017English

Emerging Role for Mammalian Target of Rapamycin in Male Fertility

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2017English

Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck

Cancer Research
Cancer ResearchOncology
2005English

Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2014English

Retraction: Mammalian Target of Rapamycin Inhibitors for Treatment in Tuberous Sclerosis

Korean Journal of Pediatrics
Child HealthPediatricsPerinatology
2013English

Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports
NeuroscienceNeurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy